New approved medication for Premature Ejaculation
PRILIGY®. New approved medication for Premature
Ejaculation available for New Zealand men
Janssen-Cilag announced that PRILIGY® (dapoxetine)
is now approved and available for use in New Zealand for the
treatment of premature ejaculation (PE) in men 18-64 years
of age.
PE is a common men’s medical condition, but it is rarely talked about. However, it is widespread and could affect the quality of life of an estimated 250,000 New Zealand men and their partners[1].
Dr. Warrick White, an Auckland GP who specialises in men’s sexual health explains, “Despite up to 20-24% of men over 24 years of age experiencing PE at some point in their lives[2], the social stigma attached to the condition may cause men to be embarrassed and reluctant to talk to a doctor about ways to improve their condition”.
PE can be a distressing condition that can be present from the first sexual encounter or can develop later in life for a variety of reasons. Nearly 1 out of 4 men with PE (24.4%) reports significant levels of anxiety[3].
The symptoms of PE are: a
short time to ejaculation, not being able to control when
ejaculation happens and distress relating to either of these
situations.
PRILIGY® is a medicine specifically
developed for the treatment of PE. It is an oral tablet that
can be taken approximately 1-3 hours before sex is
anticipated. PRILIGY® is an unfunded medicine (men will
need to pay for it) and available only with a
prescription.
For further information on PRILIGY® visit www.priligy.co.nz
ENDS